PAREXEL launches new service to optimize management of human biological samples

PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today launched its Biological Sample Lifecycle Management service, enabling optimal use of human biological samples. The new service enables biopharmaceutical clients to more efficiently manage their often irreplaceable patient biological sample assets from informed consent and collection at site, through in-study laboratory analysis, data generation and future use. The offering combines PAREXEL’s laboratory logistics and genomic medicine expertise with BioFortis consent and sample tracking software.

Human biological samples are essential to global drug development, particularly in areas such as personalized, precision and genomic medicine. PAREXEL’s new offering helps clients maintain sample integrity, security and compliance with changing regulations and guidelines. In addition, the service provides advanced oversight of samples across the complex ecosystem of laboratories, biorepositories and research and development facilities.

“Today, biopharmaceutical companies are experiencing an increased demand to provide full visibility into the chain of custody and consent status of human samples throughout the entire lifecycle, which involves complex logistics and data flows,” said Sanjay Vyas, Corporate Vice President and Global Head, Clinical Trial Supplies and Logistics, PAREXEL. “With this new offering, PAREXEL is leveraging its wide range of expertise to help clients optimize sample management to meet this demand and ultimately accelerate clinical development cycles so new medicines can reach patients sooner.”

The Biological Sample Lifecycle Management offering combines PAREXEL’s services with BioFortis’ Labmatrix software, a technology-enabled solution for clinical trial sample and consent tracking allowing study teams to monitor samples across a complex study ecosystem. The offering is the latest addition to PAREXEL’s Connected Journey of more than 40 data-driven services and is currently available worldwide. Demonstrations of the service will be provided at the BioFortis booth (#204) today through Thursday, February 15 during the 9th Annual SCOPE Summit for Clinical Ops Executives, taking place in Orlando, FL.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Parexel. (2019, June 20). PAREXEL launches new service to optimize management of human biological samples. News-Medical. Retrieved on September 22, 2021 from https://www.news-medical.net/news/20180213/PAREXEL-launches-new-service-to-optimize-management-of-human-biological-samples.aspx.

  • MLA

    Parexel. "PAREXEL launches new service to optimize management of human biological samples". News-Medical. 22 September 2021. <https://www.news-medical.net/news/20180213/PAREXEL-launches-new-service-to-optimize-management-of-human-biological-samples.aspx>.

  • Chicago

    Parexel. "PAREXEL launches new service to optimize management of human biological samples". News-Medical. https://www.news-medical.net/news/20180213/PAREXEL-launches-new-service-to-optimize-management-of-human-biological-samples.aspx. (accessed September 22, 2021).

  • Harvard

    Parexel. 2019. PAREXEL launches new service to optimize management of human biological samples. News-Medical, viewed 22 September 2021, https://www.news-medical.net/news/20180213/PAREXEL-launches-new-service-to-optimize-management-of-human-biological-samples.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
PAREXEL International expands clinical trial site alliance network